| 370088 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib |
2018-07-01 |
10.2147/dddt.s166402 |
Duan Wendu, Liu Yan |
| 370087 |
BMJ OPEN |
Does early intervention improve outcomes in the physiotherapy management of lumbar radicular syndrome? Results of the POLAR pilot randomised controlled trial |
2018-07-01 |
10.1136/bmjopen-2018-021631 |
Reddington Michael, Walters Stephen J, Cohen Judith, Baxter Susan K, Cole Ashley |
| 370086 |
DOSE-RESPONSE A PUBLICATION OF INTERNATIONAL HORMESIS SOCIETY |
A Comet Assay for DNA Damage and Repair After Exposure to Carbon-Ion Beams or X-rays in Saccharomyces Cerevisiae |
2018-07-01 |
10.1177/1559325818792467 |
Zhang Miaomiao, Cao Guozhen, Guo Xiaopeng, Gao Yue, Li Wenjian, Lu Dong |
| 370085 |
CANCER MANAGEMENT AND RESEARCH |
Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone |
2018-07-01 |
10.2147/cmar.s161871 |
Luo Yi, Tang Fan, Wang Yitian, Zhou Yong, Min Li, Zhang Wenli, Shi Rui, Duan Hong, Tu Chongqi |
| 370084 |
BMJ OPEN |
Using home sensing technology to assess outcome and recovery after hip and knee replacement in the UK: the HEmiSPHERE study protocol |
2018-07-01 |
10.1136/bmjopen-2018-021862 |
Grant Sabrina, Blom A W, Whitehouse Michael R, Craddock Ian, Judge Andrew, Tonkin Emma L, Gooberman-Hill Rachael |
| 370083 |
DOSE-RESPONSE A PUBLICATION OF INTERNATIONAL HORMESIS SOCIETY |
Influence of Individual Radiosensitivity on the Adaptive Response Phenomenon: Toward a Mechanistic Explanation Based on the Nucleo-Shuttling of ATM Protein |
2018-07-01 |
10.1177/1559325818789836 |
Devic Clément, Ferlazzo Mélanie L., Foray Nicolas |
| 370082 |
ONCOTARGETS AND THERAPY |
18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients |
2018-07-01 |
10.2147/ott.s160456 |
Zhu Wenyao, Zhang Yan, Kong Li, Huang Yong, Zheng Jinsong, Wang Renben, Li Minghuan, Yu Jinming |
| 370081 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2? |
2018-07-01 |
10.2147/dddt.s169358 |
Yasar Umit |
| 370080 |
BMJ OPEN |
Protocol for the mixed-methods development of a concussion-specific health-related quality of life outcome measure based on the international classification of functioning, disability and health |
2018-07-01 |
10.1136/bmjopen-2018-022240 |
van Ierssel Jacqueline, Sveistrup Heidi, Marshall Shawn |
| 370079 |
DOSE-RESPONSE A PUBLICATION OF INTERNATIONAL HORMESIS SOCIETY |
Enhancing and Extending Biological Performance and Resilience |
2018-07-01 |
10.1177/1559325818784501 |
Leak Rehana K., Calabrese Edward J., Kozumbo Walter J., Gidday Jeffrey M., Johnson Thomas E., Mitchell James R., Ozaki C. Keith, Wetzker Reinhard, Bast Aalt, Belz Regina G., Bøtker Hans E., Koch Sebastian, Mattson Mark P., Simon Roger P., Jirtle Randy L., Andersen Melvin E. |
